Apellis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The Company is engaged in the discovery and development of novel therapeutic compounds for autoimmune and inflammatory diseases.
$42.66 +0.71 (1.69%)
As of 05/27/2022 15:59:58 EST IEX book CBOE book
2022 © Stock Market MBA, Inc.